TP53 and head and neck cancer: Consistent with previous reports (Kennedy and Lowe, 2022), p53 mutational analysis in head and neck cancer revealed that p53 mutations mainly target the DNA binding domain, encompassing missense and deletion mutations (Figure 4D).